Key messages Dele O Abegunde, et al. Lancet 2007; 370: 1929-38.

Slides:



Advertisements
Similar presentations
Key messages Stephen S Lim, et al. Lancet 2007; 370:
Advertisements

{ China’s Health Transitions Diseases of poverty and affluence Tina Phillips Johnson, PhD Saint Vincent College October 27, 2013.
Did you know?? people died from chronic diseases in 2005.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Gojka Roglic THE GLOBAL BURDEN OF DIABETES AND.
Introduction to Public Health January 29,
Stroke - the size of the problem. What is a stroke? What is a transient ischaemic attack? What is the size of the problem?
Ann Levin, Colleen Burgess, Lou Garrison, Chris Bauch, and Joseph Babigumira Measles Initiative Meeting Washington, D.C. September 13,
Global Immunization Performance Update through 2011.
Child deaths: Causes and epidemiological dimensions Robert E. Black, M.D., M.P.H. Johns Hopkins Bloomberg School of Public Health.
Non-communicable diseases David Redfern
Measurement Measuring disease and death frequency FETP India.
Sattar N, et al. Lancet 2010;375: Flow diagram of literature search to identify randomised placebo-controlled and standard care-controlled statin.
中国农村心血管病防治面临的挑战 Challenges in prevention and control of CVD in Rural China Yangfeng Wu, MD, PhD The George Institute for Global Health at Peking University.
Global and Regional estimates of the Burden Due to Ambient Air Pollution: results from GBD ST AFRICA/MIDDLE-EAST EXPERT MEETING AND WORKSHOP ON THE.
Health Determinants, Measurements, and Trends
Source: WHO Global Burden of Disease Report Update 2004, Geneva 2008 Global Burden of Disease: chronic NCD responsible for high rates of premature mortality.
Number of participants with diabetes by trial Cholesterol Treatment Trialists' (CTT) Collaborators Lancet 2008;371:
Measures of the health status of Australians. Sources of health data and statistics in Australia Australian Bureau of Statistics (ABS), Australia’s national.
Economic and Social Aspects of NCDs SDE Seminar Series/PAHO 25 April, 2012 Rachel Nugent.
The Chronic Disease Prevention model and its use in the definition of public health policies Jeremy Lauer, PhD Health Systems Financing World Health Organization.
Klaus F. Rabe MD, PhD and the Challenges of Chronic Respiratory Disease...
Pharmacy in Public Health: Describing Populations Course, date, etc. info.
Global burden of disease study : Past, present, and future
Non-communicable diseases (NCDs) include:
Measures of the health status of Australians
Rome Cardiology Forum 2014 Update on life-style and cardiovascular prevention The dimension of the problem Rome Cardiology Forum January 29, 2014.
DR GHULAM NABI KAZI WHO Country Office Pakistan
Projected global distribution of total deaths (58 million) by major cause, 2005 Kathleen Strong et al, Lancet 2005; 366: 1578–82.
Non Communicable Diseases State of Qatar
Mortality projections
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
Non-communicable diseases (NCDs) include:
Change (with 95% CI) in outcomes by duration of type 2 diabetes
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment 
Mortality Amenable to Health Care: U. S
Relative risk of major events with atenolol vs placebo
وضعیت موجود مرگ و میر و علل مرگ غیر مادری در افراد سال کارشناس اداره سلامت میانسالان معصومه آرشین چی همدان 27 و 28 تیرماه 1396.
Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half
Figure 3 Stroke-related deaths and DALYs by country development status
Informing NCD control efforts in India on the eve of Ayushman Bharat
Births and Deaths.
Regional contributions of six preventable risk factors to achieving the 25 × 25 non- communicable disease mortality reduction target: a modelling study 
Volume 384, Issue 9941, Pages (August 2014)
The worldwide association between mean annual temperature and age-adjusted, sex-adjusted, income-adjusted and obesity-adjusted prevalence of raised fasting.
Volume 375, Issue 9725, Pages (May 2010)
Mortality risks in children aged 5–14 years in low-income and middle-income countries: a systematic empirical analysis  Prof Kenneth Hill, PhD, Linnea.
Baseline Characteristics
Mortality Amenable to Health Care
Key messages Perviz Asaria, et al. Lancet 2007; 370:
Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
Volume 393, Issue 10178, Pages (March 2019)
Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha 
How is population measured?
Cause of death Treatment-arm events, % (n=45 054)
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Age-specific mortality rates from CHD and stroke in women and men in 2010 in selected countries. Age-specific mortality rates from CHD and stroke in women.
Different measures of health status of Australians
Baseline Characteristics by hs-CRP
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
PROSPER: trial design                                                                                                                                                                 
Two Centuries of Divergence; ‘4C Countries’ Then Converged
Baseline predictors for risk of cardiovascular events or all-cause mortality among immigrants with language barriers (N = 87,707). *Adjustment for all.
Trajectories over the 9 years of follow-up of HbA1c in all participants (n = 4,080 at baseline), stratified by the presence of a family history of diabetes,
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
WASH—World Action on Salt and Health
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Trends in mortality by age-groups and select CVDs among adults with diabetes. Trends in mortality by age-groups and select CVDs among adults with diabetes.
Japan Last updated: April 2019.
Trends of ASMR of stroke by sex in China, 1994–2013
Presentation transcript:

Key messages Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Projected age-standardised death rates for 2005 from chronic diseases (per 100 000), for all ages and both sexes in 23 selected countries Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Millions of projected deaths and DALYs for chronic diseases as a proportion of deaths and DALYs for all causes in 23 selected countries for 2005, 2015, and 2030 Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Decomposition of projected change in numbers of chronic disease deaths into demographic and epidemiological components, in 23 selected countries, 2005-30 CVD=cardiovascular disease. The diff erence between the total change in numbers of deaths from 2005 to 2030 and the sum of the demographic and epidemiological components is due to the interaction between demographic and epidemiological components. Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Projected global deaths (millions) for major chronic disease groups and other causes of death in 23 selected countries, 2005-15 Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Trends in chronic disease risk factors - the situation in Brazil Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Projected foregone national income due to heart disease, stroke, and diabetes, and cumulative GDP gains through achievement of a global goal of an additional 2% annual reduction in mortality due to chronic diseases, 2006-15 Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Cumulative deaths averted and years of life gained by an additional 2% annual reduction in chronic death rates in 23 selected countries, 2006-15 Dele O Abegunde, et al. Lancet 2007; 370: 1929-38

Projected life expectancy at birth and healthy life expectancy at birth for 23 selected countries in 2005 and 2015 under the baseline and global goal projection scenarios Dele O Abegunde, et al. Lancet 2007; 370: 1929-38